Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial
This study will evaluate the main hypothesis that supplementation with vitamins A, B, C, D, and E significantly improves the severity and mortality rate in ICU patients with COVID-19.Trial designThis study is a randomized, single-blinded, two-arm (1:1 ratio) parallel group clinical trial.ParticipantsWe are conducting this study in patients with COVID-19 admitted to intensive care units at the Imam Khomeini Hospital Complex in Tehran, Iran.The inclusion criteria are as follows: (1) aged between 20 and 60 years, (2) both male and female patients with COVID-19, (3) clinical or definitive diagnosis (using polymerase chain r...
Source: Trials - July 5, 2020 Category: Research Source Type: clinical trials
Corneal Crosslinking Treatment Study
Condition: Progressive Keratoconus Interventions: Procedure: Corneal crosslinking: CXL (UVA 9mW/cm2); Drug: Isotonic riboflavin; Drug: Hypotonic riboflavin; Procedure: Iontophoresis Sponsor: Region Skane Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2020 Category: Research Source Type: clinical trials
